You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Emerging Advances in Reducing Renal Complications of T2D

  • Authors: George L. Bakris, MD; Meg Jardine, MBBS, PhD; Steve Vacalis, DO; Linda Awdishu, PharmD, MAS
  • CME / CE Released: 6/28/2019
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 6/28/2020
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care physicians, nephrologists, diabetologists and endocrinologists, nurses, nurse practitioners, and other health care professionals who treat patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).

The goal of this activity is to improve awareness of newer uses of SGLT2 sodium-glucose cotransporter 2 (SGLT2) inhibitors.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Gaps in current management of CKD
    • Mechanism of action (MOA) for sodium glucose co-transporter 2 (SGLT2) inhibitor use in treating CKD
    • Renal-related safety and efficacy data for SGLT2 inhibitors


Disclosures

It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity, and scientific rigor. All persons involved in the selection, development, and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms: 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity.


Moderator

  • George L. Bakris, MD

    Professor of Medicine
    Director
    AHA Comprehensive Hypertension Center
    University of Chicago Medicine
    Chicago, Illinois

    Disclosures

    Disclosure: George L. Bakris, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: KBP Biosciences; Merck & Co., Inc.; Novo Nordisk; Relypsa, Inc.

Faculty

  • Meg Jardine, MBBS, PhD

    Associate Professor of Medicine
    The George Institute for Global Health
    Newtown, New South Wales, Australia

    Disclosures

    Disclosure: Meg Jardine, MBBS, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Akebia Therapeutics; Baxter; Boehringer Ingelheim Pharmaceuticals, Inc.; CSL Behring; Vifor Pharma
    Served as a speaker or a member of a speakers bureau for: Amgen Inc.; Janssen Pharmaceuticals; Roche
    Received grants for clinical research from: Amgen Inc.; Baxter; CSL Behring; Eli Lilly and Company; Gambro; Merck & Co., Inc.
    Other: Steering Committee for trial sponsored by Janssen Pharmaceuticals

  • Steve Vacalis, DO

    Editorial Board Member
    ADA's "Clinical Diabetes"
    Family Practice Physician
    CaroMont Family Medicine
    Gastonia, North Carolina

    Disclosures

    Disclosure: Steve Vacalis, DO, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals; Novo Nordisk; Salix Pharmaceuticals, Inc.
    Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals; Novo Nordisk; Salix Pharmaceuticals, Inc.

Course Director

  • Linda Awdishu, PharmD, MAS

    Associate Professor of Clinical Pharmacy
    Chair, Division of Clinical Pharmacy
    Director of Interprofessional Education and Simulation
    Skaggs School of Pharmacy and Pharmaceutical Sciences
    University of California, San Diego
    La Jolla, California

    Disclosures

    Disclosure: Linda Awdishu, PharmD, MAS, has disclosed no relevant financial relationships

Editor

  • Anne G. Le, PharmD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Anne G. Le, PharmD, has disclosed no relevant financial relationships.

CE Reviewer

  • Esther Nyarko, PharmD

    Associate CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

Project staff, meeting planners, planning committee, CME committee reviewers, and CME peer reviewers do not have any relevant financial relationships to disclose. The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California San Diego School of Medicine.


Accreditation Statements

    For Physicians

  • The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of California, San Diego School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity is in compliance with California Assembly Bill 1195 which requires CME courses with patient care components to include curriculum in the subjects of cultural and linguistic competencies. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or have limited ability to speak English, direct communication in the patient's primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UC San Diego CME website at http://cme.ucsd.edu

    Contact This Provider

    For Nurses



  • In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Emerging Advances in Reducing Renal Complications of T2D

Authors: George L. Bakris, MD; Meg Jardine, MBBS, PhD; Steve Vacalis, DO; Linda Awdishu, PharmD, MASFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / CE Released: 6/28/2019

Valid for credit through: 6/28/2020

processing....

 

  • Print